Please use symbol entry at top right of page to search

Lymphedema Treatment Market Size Will Reach USD 1,735.36 Million by 2030, With 9.5% CAGR Growth: Polaris Market Research

NEW YORK, June 15, 2022 /PRNewswire/ -- Polaris Market Research recently published a research report on "Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030" in its research database.

Polaris_Market_Research_Logo

According to recent research study, the global lymphedema treatment market size & share is expected to grow at a CAGR of 9.5% between 2022 and 2030. The lymphedema treatment industry revenue of USD 786.53 Million in 2021 is expected to grow up to USD 1,735.36 Million by 2030.

What is Lymphedema Treatments? How Big is Lymphedema Treatment Market Size?

  • Report Overview

Lymphedema is a long-term condition in which lymph fluid builds up in the fatty tissues, causing swelling and discomfort. Lymphedema usually affects the arms and both legs. Women who have undergone treatment for breast cancer could also develop the condition. It can occur within days and up to 30 years after treatment for breast cancer. Lymphedema is not curable and can have a long-term effect on the individual. However, the condition can be treated with therapies, surgeries, and lymphovenous transplants at its initial stage. These treatments focus on managing symptoms to improve quality of life.

Lymphedema can be classified into primary and secondary. Primary lymphedema occurs because of a genetic condition while secondary lymphedema occurs due to disability in the lymphatic system. Other symptoms of this chronic condition include tingling, numbness, achiness, feelings of fullness and tightness, and changes in the skin. The lymphedema treatment market is expected to grow at a significant rate in the forecast period.

Request Sample Copy of "Lymphedema Treatment Market" Research Report @ https://www.polarismarketresearch.com/industry-analysis/lymphedema-treatment-market/request-for-sample

Industry Developments

  • In August 2021, AIROS Medical, a designer, manufacturer, and distributor of compression therapy devices and the fist assist devices, a medical device firm together announced an exclusive U.S. distribution deal for fist assist fa-1 compression device.
  • In September 2020, Paul Hartmann announced the partnership with Apollo Hospitals Group in India and West China Hospital in order to strengthen the activities of wound care clinics and ambulances, medical training, and products and services.

Key Companies Covered in this Report Are:

  • AIROS Medical Inc.
  • Avet Pharmaceuticals Inc.
  • Bio-compression Systems
  • Cardinal Health
  • Convatec Inc.
  • Essity (BSN medical GmbH)
  • Huntleigh Healthcare Limited
  • JUZO
  • Koya Medical
  • Lohmann & Rauscher
  • Medi GmbH
  • Mego Afek ltd.
  • PAUL HARTMANN
  • SIGVARIS GROUP
  • Smith+Nephew HERANTIS PHARMA Plc
  • Tactile medical
  • ThermoTek

For More Information on Companies and Other Discount Offers, Request Sample PDF Here

Lymphedema Treatment Market: Growth Driving Factors

A surge in the number of cases of lymphedema and breast cancer diseases is expected to drive the lymphedema treatment market's growth. The rising prevalence of cancer cases is anticipated to create tremendous market growth opportunities. The growing research & development investment in drug discovery and rising health expenditure have fueled the requirement for healthcare facilities. Also, developments in new products for lymphedema treatment are projected to boost the growth in the overall lymphedema treatment market during the forecast period. Moreover, technological developments in lymphedema treatment approaches are further expected to accelerate the lymphedema treatment market growth in the coming years. In addition, the favorable initiatives by the government and reimbursement guidelines are likely to favor market growth.

Directly Purchase a copy of report with TOC @ https://www.polarismarketresearch.com/checkouts/12941

Lymphedema Treatment Market: Report Scope & Research Dynamics

Report Attribute

Details

Revenue forecast in 2030

USD 1,735.36 Million

CAGR Valuation

9.5% from 2022 - 2030

Base Year

2021

Forecast Year

2022 - 2030

No. of Report Pages

~110 Pages

No of tables and figures

85 Tables and 13 Figures

Top Market Companies

AIROS Medical Inc., Avet Pharmaceuticals Inc., Bio-compression Systems, Cardinal Health, Convatec Inc., Essity (BSN medical GmbH), Huntleigh Healthcare Limited, JUZO, Koya Medical, Lohmann & Rauscher, Medi GmbH, Mego Afek ltd., PAUL HARTMANN, SIGVARIS GROUP, Smith+Nephew HERANTIS PHARMA Plc, Tactile medical, and ThermoTek.

Segments Covered

By Treatment Type, By Affected Area, By End-User, By Region

Customization Options

Customized purchase options are available to meet any research needs. Explore customized purchase options

 

Lymphedema Treatment Market: Segmentation

  • Based on end-user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. The hospital segment is expected to witness the market over the forecasting years owing to the rise in the number of patients coming directly to the hospital for diagnostic and treatment of lymphedema.
  • On the basis of treatment type, the global lymphedema treatment market is categorized into compression therapy, surgery, drug therapy, laser therapy, and others. Compression therapy accounted for the largest market share as this therapy efficiently controls the disease symptoms.
  • Based on the affected area, the market is bifurcated into lower extremity, upper extremity, and genitalia. Among these, the lower extremity segment is anticipated to witness the highest market share because lymphedema majorly affected the lower extremities.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/lymphedema-treatment-market/inquire-before-buying

Geographic Overview: Lymphedema Treatment Market

Based on geography, North America dominated the market with the largest share in the global market in 2021 owing to the growing technological advancements in the healthcare sector in the region. Also, the growing awareness about IgG4-related diseases is likely to create enormous market growth opportunities. Also, the increasing prevalence of lymphedema in countries such as the U.S and Canada due to the increased presence of breast cancer in the countries is expected to lead the market during the forecast period.

Moreover, the Asia Pacific region is expected to exhibit the largest share in the market over the forecast period. This growth can be attributed to the growing prevalence of chronic diseases, developments in healthcare infrastructure, and increasing R&D activities of lymphedema treatment approaches by government & pharmaceutical firms.  Emerging economies such as India and China are experiencing faster growth which is expected to positively favor the lymphedema treatment market growth. China is leading the Asia-Pacific market owing to increasing disposable income in the country.

Browse the Detail Report "Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/lymphedema-treatment-market

Frequently Asked Questions

  • Which are the major companies operating in the global lymphedema treatment market?
  • Which is the global major types/application in the lymphedema treatment market?
  • Which are the prominent players in the global lymphedema treatment market?
  • What are the driving factors fueling the growth of the lymphedema treatment market?
  • Which region accounted for the largest share in the market?
  • What are the threats to business and the impact of the current scenario on growth and market perception?
  • How will the market change in the next years?
  • Which area offers the most significant benefit for the global lymphedema treatment market?

Polaris Market Research has segmented the lymphedema treatment market report on the basis of treatment type, affected area, end-user, and region:

Lymphedema Treatment Market: By Treatment Type Outlook

  • Compression Therapy
  • Surgery
  • Drug Therapy
  • Laser Therapy
  • Others

Lymphedema Treatment Market: By Affected Area Outlook

  • Lower extremity
  • Upper extremity
  • Genitalia

Lymphedema Treatment Market: By End-User Outlook

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Browse More Relevant Reports:

  • Medical Writing Market Share, Size, Trends, Industry Analysis Report, By Type (Medical Writing, Scientific Writing, Regulatory Writing, Others); By Application, By End-User (Pharmaceutical Companies, CRO, Others); By Region; Segment Forecast, 2022 – 2030
  • Organ Preservation Market Share, Size, Trends, Industry Analysis Report, By Solution; By Technique; By End-User (Organ Transplant Centers, Hospitals, Specialty Clinics); By Organ Type (Kidney, Liver, Lung, Heart, Pancreas); By Region; Segment Forecast, 2022 – 2030
  • Population Health Management Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Services); By End-Use (Healthcare Providers, Healthcare Payers, Others); By Mode Of Delivery; By Region; Segment Forecast, 2022 – 2030
  • Pharmacovigilance Market Share, Size, Trends, Industry Analysis Report, By Service, By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-Use, By Region; Segment Forecast, 2022 – 2030
  • Medical Fiber Optics Market Share, Size, Trends, Industry Analysis Report, By Fiber Type (Single Mode Optical, Multimode Optical), By Application (Endoscopic Imaging, Laser Signal Delivery, Biomedical Sensing, Illumination, Others) By Region; Segment Forecast, 2022 - 2030

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow US: LinkedIn twitter

Logo: https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/lymphedema-treatment-market-size-will-reach-usd-1-735-36-million-by-2030--with-9-5-cagr-growth-polaris-market-research-301568594.html

SOURCE Polaris Market Research

Search News

Filter Results

Publication Date
Topic
Provider
  • All

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.